E-mail pageRalph R. Weichselbaum, MDD.K. Ludwig Professor of Radiation and Cellular OncologyChairman, Department of Radiation and Cellular OncologyDr. Ralph Weichselbaum specializes in the experimental treatment of advanced gastrointestinal malignancies. His research examines the effect of chemoradiation inducible gene therapy on pancreatic and rectal cancers. Dr. Weichselbaum's research interests include how radiation therapy attacks blood vessels and how radiation therapy regulates genes. His research has been funded by the National Institutes of Health for more than 30 years. He is also an editor of "Cancer Medicine 7," a definitive reference compiled to help oncologists and internists apply scientific principles to clinical practice. Practice LocationUniversity of Chicago Hospitals
Year Started Practice1975 Board CertificationRadiation Oncology Medical SchoolUniversity of Illinois, Chicago InternshipHighland-Alameda County Hospital, Oakland, CA Residency and FellowshipHarvard Medical School MembershipInstitute of Medicine Language SpokenEnglish Office Phone(773) 702-6870 Office Fax(773) 834-7233 Office Postal AddressRalph Weichselbaum, MD
|
Clinical Interests
Request an appointment online
Read More About Dr. WeichselbaumDr. Weichselbaum and colleagues report that targeted radiation therapy can control cancer in select patients with cancer that has spread (metastatic disease) to only a few sites. Dr. Weichselbaum's research team found that using drugs to prevent the growth of new blood vessels enhances the anti-tumor effects of radiation therapy. Selected PublicationsView a partial list of Dr. Weichselbaum's publications through the National Library of Medicine's PubMed online database. |
The University of Chicago Medical Center | 5841 S. Maryland Avenue | Chicago, IL 60637